These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 26859670)

  • 21. High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer.
    Sura S; Yorke E; Jackson A; Rosenzweig KE
    Cancer J; 2007; 13(4):238-42. PubMed ID: 17762758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.
    Krasna MJ; Gamliel Z; Burrows WM; Sonett JR; Kwong KF; Edelman MJ; Hausner PF; Doyle LA; DeYoung C; Suntharalingam M
    Ann Thorac Surg; 2010 Jan; 89(1):200-6; discussion 206. PubMed ID: 20103235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
    Rengan R; Mitra N; Liao K; Armstrong K; Vachani A
    Lancet Oncol; 2012 Dec; 13(12):1203-9. PubMed ID: 23164952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.
    Al-Shamsi HO; Al Farsi A; Ellis PM
    Clin Lung Cancer; 2014 Jul; 15(4):274-80. PubMed ID: 24685356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy.
    Sibley GS; Mundt AJ; Shapiro C; Jacobs R; Chen G; Weichselbaum R; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1001-7. PubMed ID: 7493826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
    Sampath S; Hall M; Schultheiss TE
    Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer].
    Su M; Gu Y; Su S; Lu B
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological response and prognosis of stage III non-small cell lung cancer patients treated with induction chemoradiation.
    Isobe K; Hata Y; Sakaguchi S; Sato F; Takahashi S; Sato K; Sano G; Sugino K; Sakamoto S; Takai Y; Mitsuda A; Terahara A; Shibuya K; Takagi K; Homma S
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):260-6. PubMed ID: 22897895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
    Gielda BT; Marsh JC; Zusag TW; Faber LP; Liptay M; Basu S; Warren WH; Fidler MJ; Batus M; Abrams RA; Bonomi P
    J Thorac Oncol; 2011 Jun; 6(6):1079-86. PubMed ID: 21532501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in untreated early stage non-small cell lung cancer.
    Chadha AS; Ganti AK; Sohi JS; Sahmoun AE; Mehdi SA
    Anticancer Res; 2005; 25(5):3517-20. PubMed ID: 16101172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort.
    Van Dao T; Diep TB; Le Phuong T; Huggenberger R; Kumar A
    Front Oncol; 2022; 12():842296. PubMed ID: 35677172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Video-assisted thoracic surgery lobectomy versus open lobectomy for mini pathologic N2 non-small cell lung cancer].
    Zhou WY; Chen XF; Zhang L; Zhang HJ; Wang HB; Zhang H; Zhao MC; Liu HC
    Zhonghua Wai Ke Za Zhi; 2011 Sep; 49(9):820-4. PubMed ID: 22177438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy.
    Lee H; Ahn YC; Pyo H; Kim B; Oh D; Nam H; Lee E; Sun JM; Ahn JS; Ahn MJ; Park K; Choi YS; Kim J; Zo JI; Shim YM
    Ann Surg Oncol; 2014 Jun; 21(6):2083-90. PubMed ID: 24522994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy.
    Massabeau C; Filleron T; Wakil G; Rouquette I; Bachaud JM; Leguellec S; Delisle MB; Toulas C; Mazieres J; Cohen-Jonathan Moyal E
    Clin Lung Cancer; 2012 Jan; 13(1):59-67. PubMed ID: 21856239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients.
    Topkan E; Parlak C; Selek U
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):697-704. PubMed ID: 24035331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized study comparing the effectiveness of microwave ablation radioimmunotherapy and postoperative adjuvant chemoradiation in the treatment of non-small cell lung cancer.
    Zhao Z; Su Z; Zhang W; Luo M; Wang H; Huang L
    J BUON; 2016; 21(2):326-32. PubMed ID: 27273941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.
    Takayama K; Inoue K; Tokunaga S; Matsumoto T; Oshima T; Kawasaki M; Imanaga T; Kuba M; Takeshita M; Harada T; Shioyama Y; Nakanishi Y
    Cancer Chemother Pharmacol; 2013 Dec; 72(6):1353-9. PubMed ID: 24166107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
    Gielda BT; Mehta P; Khan A; Marsh JC; Zusag TW; Warren WH; Fidler MJ; Abrams RA; Bonomi P; Liptay M; Faber LP
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):985-91. PubMed ID: 20932684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.